Dignity Community Care

Dignity Community Care was paid $86.03M by Medicaid between Jan 2018 and Dec 2024, across 274 billing codes. Its largest line is A9150, Non-prescription drugs — 17% of everything it billed.

33Billing provider infoDIGNITY COMMUNITY CARE
SACRAMENTO, CA 95823

33aNPI1467560599assigned 08/28/2006

33bProvider typeSkilled Nursing Facility

28Total paid$86.03M

24GClaims1,303,396

24DCodes billed274

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Skilled Nursing Facility providers in California

Rank by total paid#4 of 547

Median peer was paid$73K

This provider vs. median1,175×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	237,505	$15.65M
2019	237,436	$14.82M
2020	160,654	$10.04M
2021	180,548	$11.69M
2022	165,362	$11.43M
2023	173,053	$12.08M
2024incomplete	148,838	$10.32M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
A9150	Non-prescription drugs	17%	60,638	27,244	$14.42M
0450	Emergency room services	16%	55,270	49,961	$14.08M
36415	Collection of venous blood by venipuncture	9.1%	65,736	57,268	$7.81M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.3%	39,866	37,308	$7.13M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.3%	48,625	45,705	$7.10M
T1999	Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks"	6.9%	21,895	12,618	$5.89M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.4%	17,138	16,128	$4.64M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.2%	9,377	8,998	$1.86M
80053	Comprehensive metabolic panel	1.7%	68,699	63,958	$1.42M
0360		1.6%	2,941	2,663	$1.39M
G0378	Hospital observation service, per hour	<1%	790	713	$852K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	6,095	5,957	$773K

262 more codes

70450	Computed tomography, head or brain; without contrast material	<1%	8,381	$728K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	5,111	$671K
71046	Radiologic examination, chest; 2 views	<1%	15,414	$589K
99499		<1%	1,758	$575K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	22,121	$575K
Z7502		<1%	13,832	$514K
0270		<1%	50,921	$508K
J3490	Unclassified drugs	<1%	71,104	$495K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	2,390	$432K
71045	Radiologic examination, chest; single view	<1%	17,849	$428K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,703	$394K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	918	$381K
0710		<1%	3,379	$363K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	72,411	$346K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	14,238	$343K
0250		<1%	3,716	$339K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,958	$336K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	10,174	$329K
0762		<1%	89	$324K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	29,952	$322K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	510	$320K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	8,769	$315K
99199	Unlisted special service, procedure or report	<1%	3,365	$262K
0750		<1%	1,106	$258K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,015	$254K
96375	Therapeutic injection; each additional sequential IV push	<1%	10,865	$249K
80048	Basic metabolic panel (calcium, ionized)	<1%	16,520	$220K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,219	$218K
59025	Fetal non-stress test	<1%	6,895	$209K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	291	$202K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,884	$197K
84484		<1%	20,281	$197K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,704	$189K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	9,752	$184K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	222	$166K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	4,687	$150K
81001		<1%	27,504	$140K
73610		<1%	2,191	$131K
T5999	Supply, not otherwise specified	<1%	686	$130K
87086	Culture, bacterial; quantitative colony count, urine	<1%	12,639	$128K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	6,756	$125K
V2632	Posterior chamber intraocular lens	<1%	930	$124K
83690		<1%	22,943	$120K
81003		<1%	12,681	$119K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	7,774	$119K
97750		<1%	4,793	$114K
0160		<1%	231	$113K
96361	Intravenous infusion, hydration; each additional hour	<1%	5,472	$111K
73630		<1%	2,393	$110K
82962		<1%	7,476	$101K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,178	$99K
73030		<1%	1,873	$94K
Z9725		<1%	3,000	$90K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,788	$90K
73562		<1%	1,958	$89K
87081		<1%	3,526	$87K
73130		<1%	1,661	$87K
93971		<1%	1,949	$86K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	97	$83K
84703		<1%	13,751	$82K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,530	$82K
76830	Ultrasound, transvaginal	<1%	2,044	$78K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,975	$77K
73110		<1%	1,465	$76K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	282	$76K
96376		<1%	2,314	$72K
76801		<1%	2,509	$69K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,537	$67K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	9,523	$65K
Q0111	Wet mounts, including preparations of vaginal, cervical or skin specimens	<1%	2,668	$64K
74018		<1%	1,699	$63K
81025		<1%	8,062	$62K
87040		<1%	6,494	$62K
87077		<1%	3,529	$61K
A9270	Non-covered item or service	<1%	11,102	$61K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,072	$60K
0324		<1%	416	$59K
10060		<1%	579	$57K
83605		<1%	8,437	$57K
83880		<1%	5,312	$57K
Z7610		<1%	9,674	$57K
97139		<1%	8,107	$57K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,948	$55K
43235		<1%	101	$53K
0760		<1%	1,048	$52K
85027		<1%	15,594	$52K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	4,484	$51K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,865	$49K
84702		<1%	5,261	$47K
J2704	Injection, propofol, 10 mg	<1%	6,738	$46K
72100		<1%	905	$44K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	5,941	$43K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	9,422	$42K
73140		<1%	564	$40K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,884	$40K
29848		<1%	127	$38K
87631		<1%	1,196	$38K
73080		<1%	596	$35K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,979	$34K
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	<1%	29	$34K
J7030	Infusion, normal saline solution , 1000 cc	<1%	15,642	$33K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,741	$31K
97803		<1%	839	$29K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	19,817	$28K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	296	$28K
0720		<1%	479	$27K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	565	$26K
0949		<1%	623	$25K
12001		<1%	421	$25K
83735		<1%	5,134	$25K
70496		<1%	216	$24K
J1815	Injection, insulin, per 5 units	<1%	2,453	$24K
70486		<1%	353	$24K
74174		<1%	81	$23K
72131		<1%	274	$23K
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	211	$22K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	850	$22K
0254		<1%	16	$22K
70498		<1%	176	$21K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	10,148	$21K
80076		<1%	2,264	$20K
73090		<1%	323	$19K
29125		<1%	709	$19K
85610		<1%	6,587	$18K
73502		<1%	539	$18K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	1,175	$18K
85379		<1%	3,144	$17K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,370	$17K
12011		<1%	254	$16K
94644		<1%	976	$16K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	107	$16K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,510	$15K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	18	$14K
86141		<1%	2,368	$14K
93017		<1%	291	$14K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,301	$13K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	6,268	$13K
86901		<1%	3,803	$13K
85730		<1%	3,184	$13K
82803		<1%	930	$13K
0301		<1%	123	$12K
0370		<1%	216	$12K
80061	Lipid panel	<1%	1,172	$12K
86885		<1%	1,437	$12K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,106	$12K
73590		<1%	329	$11K
93970		<1%	137	$11K
90715		<1%	1,667	$11K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	314	$11K
84145		<1%	1,634	$11K
87186		<1%	2,876	$11K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	3,449	$11K
0761		<1%	152	$11K
J2785	Injection, regadenoson, 0.1 mg	<1%	273	$10K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	5,168	$10K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	435	$9K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,166	$9K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,251	$9K
84443	Thyroid stimulating hormone (TSH)	<1%	1,345	$8K
J7510	Prednisolone oral, per 5 mg	<1%	29	$8K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	37	$7K
82010		<1%	802	$7K
88304		<1%	93	$7K
82550		<1%	902	$7K
97165		<1%	276	$7K
85007		<1%	2,326	$6K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	13	$6K
87147		<1%	657	$6K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	65	$6K
85651		<1%	926	$6K
97802		<1%	83	$6K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,784	$5K
97161		<1%	207	$5K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	470	$5K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	233	$5K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,691	$5K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,881	$5K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	81	$5K
86900		<1%	2,119	$5K
97799		<1%	795	$5K
87428		<1%	214	$5K
70491		<1%	43	$4K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,671	$4K
J2060	Injection, lorazepam, 2 mg	<1%	2,145	$4K
80069		<1%	327	$4K
99153	Mod sedat endo service >5yrs	<1%	53	$4K
76870		<1%	79	$4K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	149	$4K
73564		<1%	78	$3K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	162	$3K
L4386	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	46	$3K
C9399	Unclassified drugs or biologicals	<1%	128	$3K
86880		<1%	614	$3K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	127	$2K
47563		<1%	12	$2K
96367		<1%	248	$2K
J1644	Injection, heparin sodium, per 1000 units	<1%	893	$2K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	627	$2K
71020		<1%	56	$2K
72128		<1%	13	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	452	$2K
0272		<1%	153	$2K
29105		<1%	45	$2K
97162		<1%	84	$2K
X4110		<1%	54	$2K
82553		<1%	116	$2K
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	120	$1K
97010		<1%	99	$1K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	127	$1K
70360		<1%	25	$1K
C1781	Mesh (implantable)	<1%	12	$1K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	493	$1K
99070		<1%	162	$1K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	224	$1K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	12	$1K
86308		<1%	341	$994.08
29515		<1%	107	$966.52
J7050	Infusion, normal saline solution, 250 cc	<1%	485	$915.56
92610		<1%	38	$905.89
Z7500		<1%	27	$903.65
12002		<1%	12	$845.34
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	120	$801.79
92522		<1%	44	$794.24
82140		<1%	156	$789.07
84439		<1%	49	$777.39
84100		<1%	258	$700.54
76770		<1%	29	$684.84
74019		<1%	25	$671.58
J1630	Injection, haloperidol, up to 5 mg	<1%	408	$636.06
29530		<1%	38	$440.77
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	347	$397.87
73560		<1%	12	$332.68
J1170	Injection, hydromorphone, up to 4 mg	<1%	173	$314.51
76775		<1%	12	$309.02
94664		<1%	32	$262.71
29130		<1%	50	$244.56
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	26	$201.66
87634		<1%	15	$172.73
84132		<1%	19	$155.53
36600		<1%	31	$133.10
J3370	Injection, vancomycin hcl, 500 mg	<1%	146	$129.03
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	41	$128.38
97166		<1%	110	$124.74
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	413	$113.46
86780		<1%	27	$98.80
S0028	Injection, famotidine, 20 mg	<1%	50	$93.73
80164		<1%	43	$92.40
S0164	Injection, pantoprazole sodium, 40 mg	<1%	72	$78.97
J2470	Injection, pantoprazole sodium, 40 mg	<1%	32	$77.76
88720		<1%	14	$70.30
82570		<1%	12	$61.00
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	19	$50.28
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	55	$48.89
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	28	$48.57
J1953	Injection, levetiracetam, 10 mg	<1%	15	$33.28
C9113	Injection, pantoprazole sodium, per vial	<1%	45	$22.00
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	408	$14.65
J1940	Injection, furosemide, up to 20 mg	<1%	23	$3.13
84550		<1%	14	$1.10
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	40	$0.00
71101		0%	14	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	46	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNOCIE, JOSEPH (CHIEF FINANCIAL OFFICER)

Parent organizationDIGNITY COMMUNITY CARE